ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Royal Sense Limited launched seven new pharmaceutical products and a digital blood pressure monitor for the domestic market. The expansion strengthens its healthcare product portfolio.
Royal Sense Ltd launched 17 new pharmaceutical products, including Vitamin D3 shots, multivitamins, liver tonics, and dermatological creams. Available for sale from April 27, 2026, these products cater to the domestic market. This expansion significantly broadens the company's healthcare portfolio across high-growth nutraceutical and therapeutic segments.